Real world clinicopathologic observations of patients with metastatic solid tumors receiving immune checkpoint inhibitor therapy: Analysis from Kentucky Cancer Registry-Reference-Cited by-同舟云学术

Real world clinicopathologic observations of patients with metastatic solid tumors receiving immune checkpoint inhibitor therapy: Analysis from Kentucky Cancer Registry

Published:2021-02-22 Issue:6 Volume:10 Page:2054-2062
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Jacob Aasems¹^ORCID,Wu Jianrong²,Kolesar Jill³,Durbin Eric⁴,Mathew Aju¹,Arnold Susanne¹,Chauhan Aman¹

Affiliation:

1. Department of Internal Medicine University of Kentucky Lexington KY USA

2. Department of Biostatistics University of Kentucky Lexington KY USA

3. College of Pharmacy University of Kentucky Lexington KY USA

4. Cancer Research Informatics Shared Resource Facility Markey Cancer Center University of Kentucky Lexington KY USA

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3802

Reference24 articles.

1. U.S. Cancer Statistics Working Group.U.S. Cancer Statistics Data Visualizations Tool based on 2019 submission data (1999–2017). U.S. Department of Health and Human Services Centers for Disease Control and Prevention and National Cancer Institute 2020.www.cdc.gov/cancer/dataviz

2. Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval

3. Nivolumab in Previously Untreated Melanoma withoutBRAFMutation

4. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

5. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smoking status combined with tumor mutational burden as a prognosis predictor for combination immune checkpoint inhibitor therapy in non‐small cell lung cancer;Cancer Medicine;2021-09